Vázquez-Mendoza, L.H.; Mendoza-Figueroa, H.L.; GarcÃa-Vázquez, J.B.; Correa-Basurto, J.; GarcÃa-Machorro, J.
In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking. Int. J. Mol. Sci. 2022, 23, 3987.
https://doi.org/10.3390/ijms23073987
AMA Style
Vázquez-Mendoza LH, Mendoza-Figueroa HL, GarcÃa-Vázquez JB, Correa-Basurto J, GarcÃa-Machorro J.
In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking. International Journal of Molecular Sciences. 2022; 23(7):3987.
https://doi.org/10.3390/ijms23073987
Chicago/Turabian Style
Vázquez-Mendoza, Luis Heriberto, Humberto L. Mendoza-Figueroa, Juan BenjamÃn GarcÃa-Vázquez, José Correa-Basurto, and JazmÃn GarcÃa-Machorro.
2022. "In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking" International Journal of Molecular Sciences 23, no. 7: 3987.
https://doi.org/10.3390/ijms23073987
APA Style
Vázquez-Mendoza, L. H., Mendoza-Figueroa, H. L., GarcÃa-Vázquez, J. B., Correa-Basurto, J., & GarcÃa-Machorro, J.
(2022). In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking. International Journal of Molecular Sciences, 23(7), 3987.
https://doi.org/10.3390/ijms23073987